INSULIN RESISTANCE, POLYCYSTIC OVARIAN SYNDROME An Overview

Similar documents
GONADAL FUNCTION: An Overview

SEX STERIOD HORMONES I: An Overview. University of PNG School of Medicine & Health Sciences Division of Basic Medical Sciences PBL MBBS III VJ Temple

Hyperandrogenism. Dr Jack Biko. MB. BCh (Wits), MMED O & G (Pret), FCOG (SA), Dip Advanced Endoscopic Surgery(Kiel, Germany)

ROLE OF HORMONAL ASSAY IN DIAGNOSING PCOD DR GAANA SREENIVAS (JSS,MYSURU)

Polycystic Ovary Syndrome

Polycystic Ovary Syndrome

Polycystic Ovary Syndrome HEATHER BURKS, MD OU PHYSICIANS REPRODUCTIVE MEDICINE SEPTEMBER 21, 2018

SCHOOL OF MEDICINE AND HEALTH SCIENCES DIVISION OF BASIC MEDICAL SCIENCES DISCIPLINE OF BIOCHEMISTRY & MOLECULAR BIOLOGY

Polycystic Ovarian Syndrome (PCOS) LOGO

Case Questions. Polycystic Ovarian Syndrome: Treatment Goals and Options. Differential Diagnosis of Hyperandrogenic Anovulation

Dr Stella Milsom. Endocrinologist Fertility Associates Auckland. 12:30-12:40 When Puberty is PCO

RENAL TUBULAR ACIDOSIS An Overview

Polycystic Ovary Syndrome

PCOS and Obesity DUB is better treated by OCPs

Prof.Dr. Nabil Lymon Head of Internal Medicine Department

What is PCOS? PCOS THE CONQUER PCOS E-BOOK. You'll be amazed when you read this...

Polycystic ovary syndrome

HEMOLYSIS & JAUNDICE: An Overview


RENAL FUNCTION An Overview

12/13/2017. Important references for PCOS. Polycystic Ovarian Syndrome (PCOS) for the Family Physician. 35 year old obese woman

The Impact of Insulin Resistance on Long-Term Health in PCOS

Polycystic Ovarian Syndrome. Heidi Hallonquist, MD Concord Hospital Concord Obstetrics and Gynecology

THYROID HORMONES & THYROID FUNCTION TESTS

12/27/2013. Kristen Cain, MD FACOG Reproductive Medicine Institute Sanford Health, Fargo ND

PCOS Awareness Symposium Atlanta September 24 th, Preventing Diabetes & Cardiovascular Disease in PCOS

IMPACT OF NUTRITION ON GYNECOLOGICAL HEALTH OF FEMALE ADOLESCENTS

Title of Guideline (must include the word Guideline (not protocol, policy, procedure etc)

Case. 24 year old female presented to your office complaining of excess hair growth on her face and abdomen. Questions?

Overview of Reproductive Endocrinology

Endocrine control of female reproductive function

GESTATIONAL DIABETES: An Overview

DOES INSULIN RESISTANCE CAUSE HYPERANDROGENEMIA OR HYPERANDROGENEMIA CAUSES INSULIN RESISTANCE IN PCOS

By Jennifer F. Teskey, MD; Heather J. Dean, MD, FRCPC; and Elizabeth AC Sellers, MSc, MD, FRCPC. amenorrhea. Following menarche 3. How to treat PCOS.

Polycystic Ovary Syndrome

POLYCYSTIC OVARIAN SYNDROME WHERE WE ARE AT IN 2018

Diabetes: Across the Lifespan Friday, October 17, Obesity, Insulin Resistance and Type 2 Diabetes Cardiovascular Risks in Children.

Polycystic ovarian syndrome Can lifestyle modifications help?? Dr Saloni Assistant Professor, Deptt of OBG BPSGMC for Women, Khanpur Kalan

PTA/OTA 106 Unit 2 Lecture 4 Introduction to the Endocrine System

Reproductive FSH. Analyte Information

Therapeutic Cohort Results

Adolescent polycystic ovary syndrome: pathophysiology and implications of the disease

Prevalence of Polycystic Ovarian Syndrome among urban adolescent girls and young women in Mumbai

Polycystic Ovary Syndrome: Cardiovascular Disease risk

Therapeutic Cohort Results

ADRENOCORTICOTROPIN (ACTH) Hormone made by the pituitary gland that stimulates production of adrenal hormones.

13 th Annual Women s Health Day PCOS. Saturday 02/09/2017 Dr Mathias Epee-Bekima O&G Consultant KEMH

UPDATE: Women s Health Issues

PCOS. Kirtly Parker Jones MD

Abnormal Uterine Bleeding Case Studies

SAMPLE REPORT. Order Number: PATIENT. Age: 40 Sex: F MRN:

One Day Hormone Check

Hormone Balance - Female Report SAMPLE. result graph based on Luteal Phase. result graph based on Luteal Phase

Role of inositol in Reproductive Function

On Diseases Of Menstruation And Ovarian READ ONLINE

Prevalence of polycystic ovarian syndrome in the Buraimi region of Oman

EFFECT OF WEIGHT LOSS ON OVARIAN AND ADRENAL ANDROGEN SENSITIVITY. Department OB/GYN. EVMA Norfolk, Va Telephone: (804)

Polycystic ovarian disease and Endometriosis

Adrenal Glands. Adrenal Glands. Adrenal Glands. Adrenal Glands. Adrenal Glands 4/12/2016. Controlled by both nerves and hormones.

Reproductive outcome in women with body weight disturbances

International Journal of Health Sciences and Research ISSN:

X/03/$20.00/0 Endocrine Reviews 24(5): Copyright 2003 by The Endocrine Society doi: /er

Polycystic Ovary Syndrome Therapy Dr. Pilar Vigil MD, PhD, FACOG

PITUITARY: JUST THE BASICS PART 2 THE PATIENT

WEIGHT GAIN DURING MENOPAUSE EMERGING RESEARCH

Metabolic changes in menopausal transition

clinical outcome and hormone profiles before and after laparoscopic electroincision of the ovaries in women with polycystic ovary syndrome

Polycystic Ovary Disease: A Common Endocrine Disorder in Women

PCOS The intersection of sex hormones & metabolism. Educational Objectives. Presenter Disclosure Information. Polycystic Ovary Syndrome

16 YEAR-OLD OBESE FEMALE WITH OLIGOMENORRHEA

CASE 41. What is the pathophysiologic cause of her amenorrhea? Which cells in the ovary secrete estrogen?

Feedback inhibition of insulin secretion and insulin resistance in polycystic ovarian syndrome with and without obesity

lactotrophs 120 min- FSH 60 min- LH Hypothalamus GnRH pituitary Estradiol +/- Progesterone _ FSH L H Ovary Uterus Ovulation Antral follicle >2mm

Laura Stewart, MD, FRCPC Clinical Associate Professor Division of Pediatric Endocrinology University of British Columbia

POLYCYSTIC OVARIAN SYNDROME Laura Tatpati, MD Reproductive Endocrinology and Infertility. Based on: ACOG No. 108 Oct 2009; reaffirmed 2015

INFERTILITY CAUSES. Basic evaluation of the female

PCOS-Understanding the Science and Practice. Inositols. Maurizio Nordio, University Sapienza, Rome, Italy Mumbai, June 18th, 2016

Therapeutic Cohort Results

1. During the follicular phase of the ovarian cycle, the hypothalamus releases GnRH.

PCOS IN ADOLESCENTS: EARLY DETECTION AND INTERVENTION

Metformin and Pioglitazone in Polycystic Ovarian Syndrome: A Comparative Study

One Day Hormone Check

University of Cape Town

Achieving Pregnancy: Obesity and Infertility. Jordan Vaughan, MSN, APN, WHNP-BC Women s Health Nurse Practitioner Nashville Fertility Center

METABOLIC SYNDROME IN REPRODUCTIVE FEMALES

Hormonal Control of Human Reproduction

Polycystic Ovary Syndrome (PCOS):

Female Reproductive Endocrinology

JMSCR Vol 05 Issue 05 Page May 2017

I. Endocrine System & Hormones Figure 1: Human Endocrine System

Reproductive Health and Pituitary Disease

Preview of the Medifocus Guidebook on: Polycystic Ovary Syndrome Updated June 29, 2018

PREVALENCE OF METABOLIC SYNDROME IN WOMEN WITH POLYCYSTIC OVARIAN SYNDROME A CROSS SECTIONAL STUDY THE TAMILNADU. Dr.M.G.R.

Estrogen Dominant Conditions Part I

Accession #: Patient: Jane Doe Convert to pdf, Save or PRINT >> ADRENAL CHECK

Thoughts on PCOS Female Androgenization Syndrome FAS

International Journal of Current Medical And Applied Sciences.vol.1. Issue: 1, 2013, PP 11-15

woman: the laboratory s role

Clinical Guideline ADRENARCHE MANAGEMENT OF CHILDREN PRESENTING WITH SIGNS OF EARLY ONSET PUBIC HAIR/BODY ODOUR/ACNE

REI CASE(S) Laura L. Tatpati, MD Division of REI, Dept of OB/GYN KUSM - W

Transcription:

INSULIN RESISTANCE, POLYCYSTIC OVARIAN SYNDROME An Overview University of PNG School of Medicine & Health Sciences Division of Basic Medical Sciences PBL MBBS III VJ Temple 1

Insulin Resistance: What is Insulin Resistance? Tissues fail to respond to Insulin, Ability of Insulin to dispose of blood glucose in Liver, Skeletal Muscle, Adipose tissue and other peripheral tissues is compromised; May be due to: Reduced number Insulin Receptors on tissues, Low affinity of Insulin Receptors, Normal Insulin binding to receptors, but abnormal Post- Receptor responses, e.g., abnormal activation of Glucose Transport, High expression of Tumor Necrosis Factor- (TNF- ) in Adipocytes of Obese Individuals; 2

IMPORTANT TO NOTE The greater the quantity of body fat in susceptible individuals, the greater the resistance of normally Insulin-Sensitive cells to action of Insulin; Skeletal muscle has the greatest impact on whole-body glucose disposal, and hence on Insulin Resistance, When Insulin Resistance, or Reduced Insulin Sensitivity exists, the body attempts to overcome this resistance by secreting more Insulin from Pancreas; This compensatory state of Hyperinsulinemia (high insulin levels in blood) is used as a marker for Insulin Resistance Syndrome; 3

What causes Insulin Resistance? Exact mechanism for Insulin Resistance is not known, Some hypothesis have been proposed: Post-Receptor Defect in Adipose Tissue, Abnormalities in Regulation of Expression of Insulin Gene is associated with Hyperinsulinemia; Despite Insulin Resistance in Adipose Tissue and Skeletal Muscle: Ovary remains relatively sensitive to Insulin, Insulin and Insulin-like Growth Factor-1 (IGF-1) have stimulatory effects on the production of Androgen by the Ovary; 4

What are some of the characteristics of Insulin Resistance? Insulin resistance is characterized by: High Fasting Blood Glucose, High Post-glucose Loading Insulin levels (Oral Glucose Tolerance Test), Decreased Responsiveness of Tissue to Insulin driven clearance of Glucose from blood; 5

What are some of the consequences of Insulin Resistance? Some consequences of Insulin Resistance includes: Metabolic Syndrome Syndrome X, Type 2-Diabetes Mellitus (NIDDM), Obesity, Polycystic Ovarian Disease, Dyslipidemia (High Triglycerides & LDL, Low HDL); Cardiovascular disease and Hypertension, Sleep Apnoea, High Plasminogen Activator Inhibitor (PAI-1); NB: PAI-1 reduces ability to dissolve blood clots; High PAI-1 is risk factor for Heart Attack and Stroke; 6

What are some risk factors for developing Insulin Resistance? Overweight, (especially central obesity), Strong family history of Type II Diabetes Mellitus, History of Gestational Diabetes, Hypertension, Dyslipidemia, especially low HDL and High Triglycerides, Women with Polycystic Ovary Syndrome, Acanthosis Nigricans {Skin change: Velvety, Mossy, Flat Warty-like, Darkened Skin change occurring at Neck, Armpits (Axillae) and underneath breasts}; Reduced Physical Activity, Aging, Tobacco Smoking, Regular use of diuretics, Some Anti-hypertensive drugs, or Steroids can worsen Insulin Resistance; 7

How is Insulin Resistance Diagnosed? Hyperinsulinemic Euglycemic Clamp Study is the "Gold Standard" for diagnosis of Insulin Resistance, Test MUST be done under Clinical supervision: Patients is given Intravenous Infusions of Insulin and Glucose at different Doses to determine the amount of Insulin needed to control different blood glucose levels; 8

Simple diagnostic tests for Insulin Resistance: Fasting plasma Insulin Level of over 15uU/ml indicates Insulin Resistance, This plasma level of fasting insulin highly correlates with Euglycemic clamp study; Fasting Glucose to Insulin Ratio can also be use to diagnose Insulin Resistance, Haemoglobin A1c (HbA 1c ) can be use to determine if further testing is needed; 9

PCOS: What is Polycystic Ovarian Syndrome (PCOS)? Condition characterised by menstrual abnormalities and Biochemical features of Hyperandrogenism; Features of PCOS may manifest at any age: Childhood (Premature Puberty), Teenage years (Hirsutism, Menstrual Abnormalities), Early Adulthood and Middle life (Infertility, Glucose intolerance), Later Life (Diabetes Mellitus, Cardiovascular Disease); 10

What is /are the biochemical basis for PCOS? Biochemical basis of PCOS is not clearly understood; Several theories have been suggested: Evidence of Autosomal Transmission related to strong Genetic Clustering, A Gene or Series of Genes causes the ovaries to become Sensitive to Insulin stimulation, causing the ovary to overproduce Androgens, while blocking Maturation of Follicles; Major underlying disorder in PCOS is Insulin Resistance, with resultant Hyperinsulinemia stimulating excess production of Androgens by the Ovaries; 11

How does Hyperinsulinemia relate to Infertility in female? Hyperinsulinemia is Central Biochemical abnormality of PCOS; Hyperinsulinemia leads to Hyper-Androgenism: Ovarian overproduction of Testosterone, Adrenal overproduction of Androgens: Dehydroepiandrosterone Sulphate (DHEAS), Androstenedione, Increased Testosterone (or Androgens) affects HPO axis in the female, leading to abnormal production of LH and FSH; 12

Consequences of abnormal LH and FSH production: Ovarian underproduction of Estrogen, along with Abnormal production of Progesterone, Overproduction of Testosterone that ultimately leads to Amenorrhea and Infertility; 13

How does defect in Insulin metabolism in females promotes Hyper-Androgenism in PCOS? Exact mechanism whereby defects in Insulin metabolism promote increased Androgen activity in PCOS is not fully understood; Several Hypotheses have been suggested: Insulin inhibits biosynthesis of SHBG in the liver, which leads to increase plasma level of Free Testosterone, Insulin also inhibits biosynthesis of Insulin-like Growth Factor-1 (IGF-1) Binding Protein in liver, 14

Reduction in plasma levels of IGF-1 Binding Protein causes increase in plasma level of circulating Free Insulin-like Growth Factor 1 (IGF-1), which further enhances Ovarian Androgen production; In most cases of PCOS: Ovary is major site of excess Androgen production, Some women with PCOS may have an Adrenal contribution to increased Androgen production; 15

What are some consequence of Hyperinsulinemia in PCOS? Hyperinsulinemia produces Hyperandrogenism in via distinct and independent mechanisms: By stimulating Ovarian Androgen Production, By directly and Independently Reducing Plasma SHBG levels, By reducing Plasma Level of IGF-1 Binging Protein, Net result is Increased levels of Circulating Free Testosterone; 16

IMPORTANT TO NOTE An inherent (genetically determined) ovarian defect in women with PCOS is one, which makes the ovary either susceptible to or more sensitive to insulin stimulation of Androgen production; Hyperinsulinemia adversely affect Folliculogenesis and Impede Ovulation by: Increasing Intra-ovarian Androgen production, Altering secretion of Gonadotrophins, and/or directly affecting Follicular development; 17

What endocrine Abnormalities are used as diagnostic tools in PCOS? Other disease conditions must be excluded before diagnosis of PCOS can be made with any credibility Disease conditions to be excluded include: Thyroid disease, Late Onset Congenital Adrenal Hyperplasia (CAH), Hyperprolactinaemia, Androgen secreting tumours; 18

After excluding these conditions the following can then be used as diagnostic tool for PCOS: Elevated Free Testosterone activity, confirmed by High Free Androgen Index, is the currently acceptable Biochemical marker for Differential diagnosis of PCOS, High LH and Normal FSH levels in Plasma, Strong evidence of Insulin Resistance with Compensatory Hyperinsulinemia; 19

Why is relationship of Hyperinsulinemia to PCOS important from a clinical standpoint? Women with PCOS should to be evaluated for disorders associated with Insulin Resistance, e.g: Diabetes Mellitus, Hypertension, Dyslipidemia, Atherosclerosis; 20

Insulin reduction, whether achieved by Inhibition of Pancreatic Insulin Release or Improvement in Peripheral Insulin Sensitivity, is associated with a reduction in circulating Androgens in women with PCOS and Improvement in Ovarian function; 21

What are some of the consequences of PCOS? Some of the consequences include: Infertility, Irregular Menstruation, Ovarian Cysts, Darkening of the Skin Folds, Acne, Elevated Plasma Lipid Levels, Hypertension, Heart disease, Gestational diabetes, Uterine cancer; 22

Elevation of Plasminogen Activator Inhibitor-1 (PAI-1), PAI-1 is a potent inhibitor of Fibrinolysis and a predict of Myocardial Infarction, Eating disorders: May be due to link with Leptin that affects Hypothalamic release of GnRH, with important effects on reproduction, Obesity increases Risks of: Stroke, Gallbladder disease, Colon cancers, Osteoarthritis, Sleep Apnoea, and Respiratory problems NB: Not all women with PCOS have Insulin Resistance and Glucose Intolerance; 23

REFERENCES Textbook of Biochemistry with Clinical Correlations 4 th Edition. Edited by Thomas M. Delvin. Chapter on Steroid Hormone. Harper s Illustrated Biochemistry 26 th Edition; 2003; Ed. By R. K. Murray et. al. Biochemistry, By V. L. Davidson & D. B. Sittman. 3rd Edition. Hames BD, Hooper NM, JD Houghton; Instant Notes in Biochemistry, Bios Scientific Pub, Springer; UK. VJ Temple Biochemistry 1001: Review and Viva Voce Questions and Answers Approach; Sterling Publishers Private Limited, 2012, New Delhi-110 020. G Beckett, S Walker, P Rae, P Ashby, Lecture Notes: Clinical Biochemistry 7 th Ed. 2008, Blackwell Publishing, Australia. 24